Form 8-K - Current report:
SEC Accession No. 0000914475-21-000057
Filing Date
2021-11-01
Accepted
2021-11-01 16:03:23
Documents
13
Period of Report
2021-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nbix-20211101.htm   iXBRL 8-K 32005
2 EX-99.1 nbix-20210930exhibit991.htm EX-99.1 182407
  Complete submission text file 0000914475-21-000057.txt   365326

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbix-20211101.xsd EX-101.SCH 1908
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbix-20211101_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbix-20211101_pre.xml EX-101.PRE 12512
6 EXTRACTED XBRL INSTANCE DOCUMENT nbix-20211101_htm.xml XML 10761
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 211367121
SIC: 2836 Biological Products, (No Diagnostic Substances)